Elsevier on Retraction Watch: “scholarly publishing is better for it”

It’s fair to say that we’ve been watching Elsevier over the past two-plus years, and we’ve also known they’ve been watching us. Last year, Tom Reller, the company’s vice president of global public relations, wrote that we “represent the new breed of science watchdog that is able to promote the results of their own investigations quickly via the internet.”

But as Reller notes in a thoughtful post today at ElsevierConnect: Continue reading Elsevier on Retraction Watch: “scholarly publishing is better for it”

In detailed notice, radiology journal retracts lung cancer paper for likely plagiarism

The editors of Acta Radiologica have retracted a study of patients with lung cancer, with a notice that tells the whole story:

The manuscript “Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy” was submitted to Acta Radiologica on November 3, 2010 and, after a review, accepted for publication on February 26, 2011 (1). The article was published in Acta Radiol 2011;52:646–50. Authors were: Honjiang Yan, Renben Wang (corresponding author), Fen Zhao, Kubli Zhu, Shumei Jiang, Wei Zhao, and Rui Feng, from the Department of Radiation Oncology and Department of Nuclear Medicine, Shandong Tumor Hospital, Jinan, China. Continue reading In detailed notice, radiology journal retracts lung cancer paper for likely plagiarism

Radioactive fish study retracted for “significant and extensive” corrections

The authors of a study estimating how much radioactive material from two sunken Russian submarines is taken up by fish in the Barents Sea have retracted it, citing the need for “significant and extensive” corrections.

Here’s the notice, from Environmental Pollution: Continue reading Radioactive fish study retracted for “significant and extensive” corrections

Another retraction from chiropractic researchers for lack of ethics approval

Chiropractic & Manual Therapies — formerly known as Chiropractic & Osteopathy — has retracted a 2010 paper by a team of Australian researchers who failed to obtain institutional review board (IRB) approval for their studies.

As the notice for “A descriptive study of a manual therapy intervention within a randomised controlled trial for hamstring and lower limb injury prevention” explains: Continue reading Another retraction from chiropractic researchers for lack of ethics approval

Two Royal Society of Chemistry (RSC) Advances retractions, for unreliable results, surprised author

Authors of two separate studies in RSC Advances — RSC is the Royal Society of Chemistry — have retracted their papers.

Here’s one notice, for “Laser-induced gold/chitosan nanocomposites with tailored wettability applied to multi-irradiated microfluidic channels:” Continue reading Two Royal Society of Chemistry (RSC) Advances retractions, for unreliable results, surprised author

Feeling sheepish: Another retraction for Lemus, of study of whether livestock can spread chlamydia to birds

Jesús A. Lemus, the Spanish veterinary researcher whose work has been the subject of a misconduct inquiry, has another retraction for his CV. It’s his third, according to our count.

The newest retraction is from PLoS ONE:
Continue reading Feeling sheepish: Another retraction for Lemus, of study of whether livestock can spread chlamydia to birds

Did a McLuhan moment lead to retraction in Chemistry — A European Journal?

The authors of a chemistry paper are retracting it after a Columbia University chemistry researcher pointed out a fatal misinterpretation of his own work in it.

Here’s the notice in Chemistry — A European Journal: Continue reading Did a McLuhan moment lead to retraction in Chemistry — A European Journal?

Correction for MD Anderson’s Bharat Aggarwal arches eyebrows for the right reasons

We’ve written about mega-corrections that allow scientists to retrace virtually all of their steps yet preserve their publications as supposedly legitimate. And we’ve seen plenty of corrections that allow authors to assert that their conclusions are correct when evidently important pieces of data are themselves unreliable.

Now comes a correction that seems to us to strike the right chords, given the fact that editors are to a large extent at the mercy of authors in these situations. Continue reading Correction for MD Anderson’s Bharat Aggarwal arches eyebrows for the right reasons

Walk (back) an Egyptian (vulture): Another paper by Spanish vet under scrutiny retracted

With apologies to the Bangles for this post’s title, we have another vulture-related retraction from Jesús A. Lemus, the Spanish veterinary researcher whose results have come into question.

This one involves a paper that appeared in PLoS ONE in 2009, titled “Susceptibility to Infection and Immune Response in Insular and Continental Populations of Egyptian Vulture: Implications for Conservation.”

According to the notice: Continue reading Walk (back) an Egyptian (vulture): Another paper by Spanish vet under scrutiny retracted

The domino effect: More retractions of papers that cited retracted PLoS ONE GMO cassava study

Last month, we reported on a PLoS ONE paper about genetically modified cassava — or, more correctly, allegedly GMO cassava — that was being retracted because data “could not be found.” We have an update on that story, namely that a paper relying on materials from that lab will be retracted, and that authors of a review that included a figure from the graduate student who claimed to have done the work will retract part of their paper.

As a Retraction Watch commenter on our earlier post noted, referring to Claude Fauquet, the PI of the Danforth Center lab where graduate student Mohammad Abhary worked: Continue reading The domino effect: More retractions of papers that cited retracted PLoS ONE GMO cassava study